@FiercePharma: Chief Justice unloads Pfizer shares. Article | Follow @FiercePharma
From the archives: Top 10 Pharma CEO salaries of 2009. Report
> Bristol-Myers Squibb is recalling 60 million tablets of the blood pressure medication Avalide in the U.S. and Puerto Rico. Report
> Sun Pharmaceutical Industries won tentative marketing approval for a generic version of AstraZeneca's cholesterol drug Crestor. Report
> Novartis lost a U.K. appeal to overturn a ruling that invalidated its European patent for extended-wear contact lenses in a lawsuit against Johnson & Johnson. Report
> A Maryland couple has filed a wrongful death lawsuit against Pfizer, saying that a switch in formulation for its Dilantin epilepsy drug caused their son's death. Report
> GlaxoSmithKline has tapped soccer star Mia Hamm for its public health campaign to emphasize the need for adults to make vaccinations part of their overall health-and-wellness goals. Report
> Regulators approved the wider use of GlaxoSmithKline's clot-busting medicine Arixtra (fondaparinux) throughout the European Union. Report
> Marketing rights for cancer treatment Caeylx outside the U.S. will be returned to Janssen from Merck after a licensing deal expires in December. Report
> Warner Chilcott has completed the sale of $500 million in debt to finance its acquisition of the U.S. rights to the bladder treatment Enablex. Report
> AstraZeneca Pharma India said its public shareholders did not approve a special resolution to delist the company from the stock exchanges, leading its shares to fall more than 3 percent. Report
Biotech News
@FierceBiotech: Lilly research chief outlines the perfect biotech pact. Article | Follow @FierceBiotech
@JohnCFierce: Genzyme's Termeer says he's ready to go, when the price and time is right. But don't look for a snap deal with Sanofi. Report | Follow @JohnCFierce
> HIV vax researchers ponder best R&D strategies in Atlanta. Article
> Protox lines up $35M for BPH program. Story
> Sanofi's GLP-1 drug hits promising marks in PhIII diabetes trial. Report
> Sanofi pipeline review overshadowed by Genzyme maneuvers. Item
Vaccines News
> Withdrawn Sanofi Hep B vax continues to help kids. Story
> HIV vaccine researchers ponder new strategies, drop in funding. Article
> HHS chief promises cell-based flu vax in 2011. News
> Vax experts discuss trials, tribulations of malaria R&D. Report
Manufacturing News
> Xcelience boosts solid oral dosage form capabilities. News
> Lannett and Cody pass FDA muster. Story
> Service calculates API-making costs for generics. News
> India finds execs liable for manufacturing defects. Report
And Finally... A nationwide shortage of several widely used anesthetics, which has been exasperating doctors and veterinarians for months, has now spread to the country's death rows. Report